Jia-yu Zhu

circKIF4A sponges miR-127 to promote ovarian cancer progression

Y. Hu, Shunliang Sheng, Furong Yu, 2020, Aging.

circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer

Lingyan Liu, Jingkun Qin, Peng Wu, 2022, Aging.

Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction.

Jia-yu Zhu, Yan-hong Yu, M. Zhong, 2014, Early human development.

Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study

Ke-Feng Wang, Z. Xia, Jia-yu Zhu, 2015, Leukemia & lymphoma.

The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study

Cheng-Cheng Liu, Hailin Tang, Jia-yu Zhu, 2016, Journal of Cancer Research and Clinical Oncology.

Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective study

Cheng-Cheng Liu, Jia-yu Zhu, Hai-lin Tang, 2017, Journal of Cancer.

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway

Shunliang Sheng, Furong Yu, Wenjuan Tong, 2021, Aging.

Regulation of trophoblast invasion: the role of matrix metalloproteinases.

Jia-yu Zhu, Yan-hong Yu, Z. Pang, 2012, Reviews in obstetrics & gynecology.

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance

W. Fang, Chunlin Chen, Zhongqiu Lin, 2023, Advancement of science.